Therapeutic areas for approved chemical drug NDA in China 2021
In 2021, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved 160 New Drug Applications (NDA) for chemical drugs. 30 percent of all chemical drugs approved were antineoplastic drugs. Anti-infectives and drugs treating nervous system diseases were also approved in considerable numbers. A New Drug Application (NDA) is the mechanism through which pharmaceutical manufacturers propose that the regulatory body approve a new drug or biopharmaceutical for general use and sale.